Subsequently, several studies highlighted that NRP-1 was aberrantly expressed in several cancer types, including PDAC, and was involved in a plethora of cancer initiating and promoting pathways due to its distinctive ability to bind numerous growth factors and ligands [44, 45, 50–53, 60, 61]. This evidence concerns the gene NRP1 and cancer.